Company Filing History:
Years Active: 2010-2011
Title: James K Burmester: Innovator in Genetic Research
Introduction
James K Burmester is a notable inventor based in Marshfield, Wisconsin. He has made significant contributions to the field of genetic research, particularly in the areas of prostate cancer and retinal gene expression. With a total of 2 patents, Burmester's work has the potential to impact medical science and treatment options.
Latest Patents
Burmester's latest patents include the "GDEP enhancer element and use thereof to confer retinal specific gene expression." This invention focuses on isolated nucleic acids that contain functional polynucleotide sequences representing an enhancer element for the Gene Differentially Expressed in Prostate (GDEP). These molecules are instrumental in conferring retinal specific transcriptional responsiveness on associated promoters, thereby providing methods for directing retinal specific gene expression. Another significant patent is the "Genetic marker for prostate cancer," which offers a method for determining a genetic predisposition to prostate cancer in male human subjects. This method involves assessing whether the subject has the genotype GG of refSNP rs125555, indicating a genetic predisposition to prostate cancer.
Career Highlights
James K Burmester is affiliated with Marshfield Clinic, where he continues to advance his research and innovations. His work is characterized by a commitment to improving understanding and treatment of genetic conditions.
Collaborations
Burmester collaborates with esteemed colleagues, including Deanna S Cross and Michael D Caldwell, who contribute to his research endeavors.
Conclusion
James K Burmester's contributions to genetic research, particularly in prostate cancer and retinal gene expression, highlight his role as an influential inventor. His patents reflect a dedication to advancing medical science and improving patient outcomes.